Khang Chung Ngoc Vo
YOU?
Author Swipe
View article: Diagnostic value of vietnamese smell identification test in Parkinson's disease
Diagnostic value of vietnamese smell identification test in Parkinson's disease Open
The VSIT can be a valuable ancillary tool for supporting the diagnosis of PD in Vietnam. Olfactory dysfunction in PD was unrelated to the disease duration and severity. The VSIT can be applied to improve the accuracy of clinical PD diagnos…
View article: Comparing smell identification ability among different motor subtypes of Parkinson’s disease using the Vietnamese Smell Identification Test and the Brief Smell Identification Test
Comparing smell identification ability among different motor subtypes of Parkinson’s disease using the Vietnamese Smell Identification Test and the Brief Smell Identification Test Open
View article: Comparing Smell Identification Ability Among Different Motor Subtypes of Parkinson's Disease Using the Vietnamese Smell Identification Test and the Brief Smell Identification Test
Comparing Smell Identification Ability Among Different Motor Subtypes of Parkinson's Disease Using the Vietnamese Smell Identification Test and the Brief Smell Identification Test Open
View article: Development and validation of the Vietnamese smell identification test
Development and validation of the Vietnamese smell identification test Open
The Vietnamese Smell Identification Test (VSIT) demonstrated favorable validity and reliability and will allow for assessment of olfactory function in Vietnamese patients.
View article: Normative data for the Vietnamese smell identification test
Normative data for the Vietnamese smell identification test Open
Normative data provide guidance for assessing individual olfactory function. However, there were significant sex and age effects on olfactory identification scores on the VSIT. Therefore, future studies should be conducted to better adjust…
View article: Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial
Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial Open
View article: Corrigendum to ‘Adult-onset mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) syndrome with progressive sensorineural hearing loss: A case report [Radiology Case Reports 16 (2021) 1865-1869]
Corrigendum to ‘Adult-onset mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) syndrome with progressive sensorineural hearing loss: A case report [Radiology Case Reports 16 (2021) 1865-1869] Open